AC-339

N/A

Report date: 2025/01/26 15:16:34
NME

Base Information

Drug NameAC-339
Drug Alias NameAC-339
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTAR DNA binding protein 43 inhibitorsSynuclein alpha inhibitors
TargetsSynuclein alphaTAR DNA binding protein 43
Therapy Area/IndicationsNerve DegenerationAmyotrophic Lateral SclerosisFrontotemporal Dementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Santa Barbara
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California, Santa BarbaraAcelot IncMacquarie University
Inactive CompaniesN/A
Active IndicationsNerve DegenerationAmyotrophic Lateral SclerosisFrontotemporal Dementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A